BioCanvas
표적 · PALB

PALB 항체

3최다 인용
25인용된 항체
12벤더
Antibody Registry데이터 출처 · RRID CC0

논문 인용순 항체

Antibody Registry 인용수 기준 · 25종
1
Santa Cruz Biotechnology#sc-13098 RRID:AB_2241313 polyclonal
3
cited by
2
Bio-Rad#AHP1837 RRID:AB_2212089 polyclonal
1
cited by
3
Thermo Fisher Scientific#MA1-221 RRID:AB_2725592 monoclonal
1
cited by
4
Santa Cruz Biotechnology#sc-8105 RRID:AB_654768 polyclonal
0
cited by
5
Santa Cruz Biotechnology#sc-8104 RRID:AB_654770 polyclonal
0
cited by
6
Antibodies.com#A84211 +1 벤더 RRID:AB_715125 polyclonal
0
cited by
7
Atlas Antibodies#HPA002550 RRID:AB_1080419 polyclonal
0
cited by
8
Thermo Fisher Scientific#PA1-27499 RRID:AB_1091075 polyclonal
0
cited by
9
Santa Cruz Biotechnology#sc-69794 RRID:AB_1128722 monoclonal
0
cited by
10
Abcam#2524-1 RRID:AB_1267310 monoclonal
0
cited by
11
Abcam#2434-1 RRID:AB_1267368 monoclonal
0
cited by
12
Enzo Life Sciences#H00007276-M01 RRID:AB_1533874 monoclonal
0
cited by
13
abcepta#AT4395a RRID:AB_1555005 monoclonal
0
cited by
14
Abnova#PAB7028 RRID:AB_1581584 polyclonal
0
cited by
15
LSBio (LifeSpan)#LS-B2366-50 RRID:AB_1654284 polyclonal
0
cited by
16
LSBio (LifeSpan)#LS-B2595-50 RRID:AB_1666196 monoclonal
0
cited by
17
LSBio (LifeSpan)#LS-B2607-50 RRID:AB_1666197 polyclonal
0
cited by
18
Abnova#PAB4998 RRID:AB_1716585 polyclonal
0
cited by
19
Abnova#MAB1195 RRID:AB_1716587 monoclonal
0
cited by
20
LSBio (LifeSpan)#LS-B775-50 RRID:AB_1812937 polyclonal
0
cited by
21
LSBio (LifeSpan)#LS-B2864-50 RRID:AB_1939914 monoclonal
0
cited by
22
abcepta#AP6698c RRID:AB_1968382 monoclonal
0
cited by
23
GenWay Biotech Inc.#18-007-283039-0.1 ml RRID:AB_1994956 polyclonal
0
cited by
24
GenWay Biotech Inc.#18-202-336039-0.1 mg RRID:AB_1994959 polyclonal
0
cited by
25
LSBio (LifeSpan)#LS-C96084-100 RRID:AB_2033603 polyclonal
0
cited by
이 표적 항체를 국내 공급가·납기로 확인하시겠어요? 국내 구매·견적 문의 →

PALB

이 표적에 논문에서 가장 많이 인용된 항체 순으로 정리했습니다. 각 행에서 국내 견적을 요청할 수 있습니다.

Data: Antibody Registry (SciCrunch) — RRID under CC-0; product metadata per respective source. Citation counts: Antibody Registry.